Ignite Creation Date:
2025-12-24 @ 10:50 PM
Ignite Modification Date:
2025-12-24 @ 10:50 PM
Study NCT ID:
NCT04156269
Status:
UNKNOWN
Last Update Posted:
2019-11-12
First Post:
2019-11-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
BCMA-CS1 Compound CAR (cCAR) T Cells for Relapsed/Refractory Multiple Myeloma
Sponsor:
iCell Gene Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-31
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-09-01
Completion Date Type:
ESTIMATED
First Submit Date:
2019-11-06
First Submit QC Date:
None
Study First Post Date:
2019-11-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-08
Last Update Post Date:
2019-11-12
Last Update Post Date Type:
ACTUAL